About-cancer/treatment/drugs/cervical
Izidakamizwa zivunyelwe umdlavuza wesibeletho
Leli khasi libala imishanguzo yomdlavuza evunyelwe yiFood and Drug Administration (FDA) yomdlavuza womlomo wesibeletho. Uhlu lufaka amagama ejwayelekile namagama ezimpawu. Leli khasi futhi libala izinhlanganisela zezidakamizwa ezivamile ezisetshenziswa kumdlavuza womlomo wesibeletho. Izidakamizwa ngazinye ezinhlanganisweni zivunyelwe yi-FDA. Kodwa-ke, inhlanganisela yezidakamizwa uqobo ayivunyelwe, yize isetshenziswa kabanzi.
Amagama ezidakamizwa axhumanisa nezifinyezo ze-Cancer Information Information ze-NCI. Kungenzeka kube nezidakamizwa ezisetshenziswe kumdlavuza womlomo wesibeletho ezingekho ohlwini lapha.
Izidakamizwa zivunyelwe ukuvimbela umdlavuza wesibeletho
I-Cervarix (Umuthi wokugomela we-HPV Bivalent Vacomb)
IGardasil (Umuthi wokugomela we-HPV Quadrivalent)
I-Gardasil 9 (Umuthi wokugomela we-HPV Nonavalent)
Umuthi wokugomela we-Recombinant Human Papillomavirus (HPV)
Umuthi wokugomela onamandla we-Recombinant Human Papillomavirus (HPV)
Umuthi wokugomela we-Quadrivalent Human
Izidakamizwa Kuvunyelwe Ukwelapha Umdlavuza Wesibeletho
I-Avastin (Bevacizumab)
Bevacizumab
I-Bleomycin Sulfate
IHycamtin (iTototecan Hydrochloride)
I-Keytruda (Pembrolizumab)
I-Mvasi (Bevacizumab)
I-Pembrolizumab
I-Topotecan Hydrochloride
Ukuhlanganiswa Kwezidakamizwa Kusetshenziswe Emdlavuzeni Wesibeletho
IGemcitabine-Cisplatin